Antistress properties of antidepressant drugs and their clinical implications (Q37884805)

24 August 2017

1 reference

title

Antistress properties of antidepressant drugs and their clinical implications (English)

1 reference

24 August 2017

1

Francesca Calabrese

1 reference

24 August 2017

Raffaella Molteni

2

0 references

Marco A. Riva

object named as

Marco A Riva

3

0 references

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21640755

3 December 2024

publication date

27 May 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0163725811001185?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

https://api.elsevier.com/content/article/PII:S0163725811001185?httpAccept=text/plain

3 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Pharmacology & Therapeutics

3 December 2024

published in

1 reference

24 August 2017

volume

132

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

39-56

1 reference

A Syndrome produced by Diverse Nocuous Agents

24 August 2017

cites work

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/138032A0

Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

24 October 2021

1

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action

3 December 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Potential therapeutic effects of exercise to the brain.

3 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress signalling pathways that impair prefrontal cortex structure and function

3 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients

3 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of chronic mild stress on serum complement activity, saccharin preference, and corticosterone levels in Flinders lines of rats.

3 December 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology

3 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors

3 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Keeping 'trk' of antidepressant actions

3 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

3 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist

3 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Long-term effects of infant rearing condition on the acquisition of dominance rank in juvenile and adult rhesus macaques (Macaca mulatta).

3 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain

3 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

New approaches to antidepressant drug discovery: beyond monoamines

3 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal neurogenesis induced by antidepressant drugs: an epiphenomenon in their mood-improving actions

3 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults

3 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.

3 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

3 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

CRE/CREB-driven up-regulation of gene expression by chronic social stress in CRE-luciferase transgenic mice: reversal by antidepressant treatment

3 December 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice

3 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

3 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

3 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis

3 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection

3 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal volume reduction in major depression.

3 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder

3 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression

3 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development

3 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism

3 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Long-Term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms

3 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine

3 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein

3 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neuronal plasticity: a link between stress and mood disorders

3 December 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat.

3 December 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Regulation of neurogenesis by growth factors and neurotransmitters

3 December 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression

3 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

In vitro modulation of the glucocorticoid receptor by antidepressants

3 December 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

3 December 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment

3 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment

3 December 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

3 December 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Sex differences in hormonal responses to a social stressor in chronic major depression

3 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Learned helplessness: validity and reliability of depressive-like states in mice.

3 December 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Bi-phasic change in BDNF gene expression following antidepressant drug treatment

3 December 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant actions of histone deacetylase inhibitors

3 December 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

3 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Cyloserine as an antidepressant agent

3 December 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

3 December 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress

3 December 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

3 December 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Prenatal maternal stress programs infant stress regulation

3 December 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress and the brain: from adaptation to disease

3 December 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress and cognition: are corticosteroids good or bad guys?

3 December 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain corticosteroid receptor balance in health and disease

3 December 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?

3 December 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal neurogenesis: regulation by stress and antidepressants

3 December 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

3 December 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Depression: a case of neuronal life and death?

3 December 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

A neurotrophic model for stress-related mood disorders

3 December 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Regulation of adult neurogenesis by antidepressant treatment

3 December 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment

3 December 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Sustained stress-induced changes in mice as a model for chronic depression

3 December 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression

3 December 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression

3 December 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Assessing anhedonia in psychiatric patients

3 December 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Psychobiology and molecular genetics of resilience

3 December 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

A meta-analytic study of changes in brain activation in depression

3 December 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Infants and young children in orphanages: one view from pediatrics and child psychiatry

3 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Nerve growth factor promotes survival of new neurons in the adult hippocampus

3 December 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal changes in patients with a first episode of major depression

3 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.

3 December 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression

3 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression

3 December 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study

3 December 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression

3 December 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress.

3 December 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain.

3 December 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress during development: Impact on neuroplasticity and relevance to psychopathology

3 December 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

CREB, neurogenesis and depression

3 December 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Maternal stress or anxiety in pregnancy and emotional development of the child

3 December 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Predictive adaptive responses in perspective

3 December 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression

3 December 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation

3 December 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression

3 December 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders?

3 December 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

3 December 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Dexamethasone suppression test in helpless rats

3 December 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Exercise, learned helplessness, and the stress-resistant brain

3 December 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic mild stress inhibits BDNF protein expression and CREB activation in the dentate gyrus but not in the hippocampus proper

3 December 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neurogenesis in the adult brain: death of a dogma

3 December 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Is it time to reassess the BDNF hypothesis of depression?

3 December 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Subtle neurologic compromise as a vulnerability factor for combat-related posttraumatic stress disorder: results of a twin study

3 December 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neurobiology of early life stress: rodent studies

3 December 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression

3 December 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Molecular regulation of adult CNS neurogenesis: an integrated view

3 December 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

3 December 2024

Stress and depression

99

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

3 December 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood

3 December 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Differential effects of antidepressants on glucocorticoid receptors in human primary blood cells and human monocytic U-937 cells

3 December 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project

3 December 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

3 December 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress

3 December 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Child health, developmental plasticity, and epigenetic programming

3 December 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The corticosteroid receptor hypothesis of depression

3 December 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

How can we realize the promise of personalized antidepressant medicines?

3 December 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists

3 December 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

3 December 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement

3 December 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant actions of the exercise-regulated gene VGF.

3 December 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Initiation and adaptation: a paradigm for understanding psychotropic drug action

3 December 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls

3 December 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker?

3 December 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The neuro-symphony of stress

3 December 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic amitriptyline treatment induces hippocampal NGFI-A, glucocorticoid receptor and mineralocorticoid receptor mRNA expression in rats

3 December 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

A decade of antidepressant development: the SSRIs and beyond

3 December 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Different responses to dexamethasone and prednisolone in the same depressed patients

3 December 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance

3 December 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats

3 December 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice

3 December 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The postnatal environment can counteract prenatal effects on cognitive ability, cell proliferation, and synaptic protein expression

3 December 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies

3 December 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Pituitary size in depression

3 December 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus

3 December 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Long-term behavioral and neuroendocrine adaptations to adverse early experience

3 December 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation

3 December 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment

3 December 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Influence of psychological variables on the activity of the hypothalamic-pituitary-adrenal axis

3 December 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Developmental determinants of sensitivity and resistance to stress

3 December 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Infantile experience and the maturation of the pituitary adrenal axis

3 December 2024

135

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The genetics of depression: a review

3 December 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression

3 December 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment

3 December 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Influence of neonatal rearing conditions on stress-induced adrenocorticotropin responses and norepinepherine release in the hypothalamic paraventricular nucleus.

3 December 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress

3 December 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.

3 December 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The yin and yang of neurotrophin action

3 December 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Cortisol levels during human aging predict hippocampal atrophy and memory deficits.

3 December 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of stress throughout the lifespan on the brain, behaviour and cognition

3 December 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Prenatal stress and long-term consequences: implications of glucocorticoid hormones

3 December 2024

145

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations.

3 December 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Ketamine and the next generation of antidepressants with a rapid onset of action

3 December 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Course of illness, hippocampal function, and hippocampal volume in major depression

3 December 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

3 December 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder

3 December 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

3 December 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment

3 December 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

3 December 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain

3 December 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Rapid induction of BDNF expression in the hippocampus during immobilization stress challenge in adult rats.

3 December 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The effect of monoamine oxidase inhibitors compared with classical tricyclic antidepressants on learned helplessness paradigm.

3 December 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

New insights into BDNF function in depression and anxiety

3 December 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

3 December 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neuroplasticity mediated by altered gene expression

3 December 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress and hippocampal plasticity

3 December 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Sex, stress and the hippocampus: allostasis, allostatic load and the aging process

3 December 2024

162

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The epigenetics of social adversity in early life: implications for mental health outcomes

3 December 2024

163

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations

3 December 2024

164

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress

3 December 2024

165

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Quantitative MRI of the hippocampus and amygdala in severe depression

3 December 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression?

3 December 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder

3 December 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

3 December 2024

169

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Learned helplessness, depression and the perception of reinforcement

3 December 2024

170

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function

3 December 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early life experience alters response of adult neurogenesis to stress

3 December 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia

3 December 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

3 December 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions.

3 December 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine

3 December 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans

3 December 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity

3 December 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine

3 December 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Dynamic DNA methylation programs persistent adverse effects of early-life stress

3 December 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression

3 December 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants

3 December 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Suppression of sucrose drinking by chronic mild unpredictable stress: a methodological analysis

3 December 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress.

3 December 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus

3 December 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Neurobiology of depression

3 December 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Animal models of neuropsychiatric disorders

3 December 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Parental depression: animal models of an adverse life event

3 December 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

3 December 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Repeated stress increases catalytic TrkB mRNA in rat hippocampus

3 December 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children

3 December 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Modulation of the human glucocorticoid receptor function by antidepressive compounds

3 December 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Cytokines and glucocorticoid receptor signaling. Relevance to major depression

3 December 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids

3 December 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

3 December 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The HPA axis in major depression: classical theories and new developments

3 December 2024

196

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

3 December 2024

197

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

3 December 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine

3 December 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Do antidepressants regulate how cortisol affects the brain?

3 December 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of early life stress on cognitive and affective function: an integrated review of human literature

3 December 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus

3 December 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures

3 December 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression

3 December 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus

3 December 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress, depression, and neuroplasticity: a convergence of mechanisms

3 December 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The NMDA receptor as a therapeutic target in major depressive disorder

3 December 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Fluoxetine increases the activity of the ERK-CREB signal system and alleviates the depressive-like behavior in rats exposed to chronic forced swim stress

3 December 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

3 December 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

3 December 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression

3 December 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal changes associated with early-life adversity and vulnerability to depression

3 December 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of early and recent adverse experiences on adrenal response to psychosocial stress in depressed adolescents

3 December 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock

3 December 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine

3 December 2024

215

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The DST as a predictor of outcome in depression: a meta-analysis

3 December 2024

217

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Emerging role of the FGF system in psychiatric disorders

3 December 2024

218

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions.

3 December 2024

219

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus.

3 December 2024

220

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effect of chronic intermittent restraint stress on hippocampal expression of marker proteins for synaptic plasticity and progenitor cell proliferation in rats

3 December 2024

221

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Lasting epigenetic influence of early-life adversity on the BDNF gene

3 December 2024

222

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model

3 December 2024

223

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression

3 December 2024

224

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects.

3 December 2024

225

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus.

3 December 2024

226

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

3 December 2024

227

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early adverse experience as a developmental risk factor for later psychopathology: Evidence from rodent and primate models

3 December 2024

228

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Elevated maternal cortisol early in pregnancy predicts third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock.

3 December 2024

229

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

3 December 2024

230

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

3 December 2024

231

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Is impaired neurogenesis relevant to the affective symptoms of depression?

3 December 2024

232

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation

3 December 2024

233

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats.

3 December 2024

234

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

3 December 2024

235

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Glucocorticoid programming

3 December 2024

236

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study

3 December 2024

238

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Untreated Depression and Hippocampal Volume Loss

3 December 2024

239

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal atrophy in recurrent major depression

3 December 2024

241

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression.

3 December 2024

242

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus.

3 December 2024

243

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features.

3 December 2024

244

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Glutamate-based antidepressants: 20 years on.

3 December 2024

245

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

3 December 2024

246

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide

3 December 2024

247

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Genetic epidemiology of major depression: review and meta-analysis

3 December 2024

248

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early determinants of behaviour: evidence from primate studies

3 December 2024

250

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal

3 December 2024

251

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Maternal care, the epigenome and phenotypic differences in behavior

3 December 2024

252

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats

3 December 2024

253

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test

3 December 2024

254

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Exposure to fox odor inhibits cell proliferation in the hippocampus of adult rats via an adrenal hormone-dependent mechanism

3 December 2024

255

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview.

3 December 2024

256

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The neurobiological consequences of early stress and childhood maltreatment

3 December 2024

257

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex

3 December 2024

258

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study

3 December 2024

259

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

3 December 2024

260

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The fibroblast growth factor system and mood disorders.

3 December 2024

261

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events.

3 December 2024

262

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice

3 December 2024

263

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

3 December 2024

264

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex.

3 December 2024

265

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study.

3 December 2024

266

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume.

3 December 2024

267

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Aberrant functional connectivity of dorsolateral prefrontal and cingulate networks in patients with major depression during working memory processing.

3 December 2024

268

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Early life stress, the development of aggression and neuroendocrine and neurobiological correlates: what can we learn from animal models?

3 December 2024

269

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Effects of early life stress on adult male aggression and hypothalamic vasopressin and serotonin

3 December 2024

270

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder

3 December 2024

271

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness

3 December 2024

272

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Defeat followed by individual housing results in long-term impaired reward- and cognition-related behaviours in rats.

3 December 2024

273

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment

3 December 2024

274

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

VEGF as a potential target for therapeutic intervention in depression

3 December 2024

275

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Epigenetic programming by maternal behavior

3 December 2024

276

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry

3 December 2024

277

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case

3 December 2024

278

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

3 December 2024

279

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS.

3 December 2024

280

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus

3 December 2024

281

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine

3 December 2024

282

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Behavioral animal models of depression

3 December 2024

283

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus

3 December 2024

284

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice

3 December 2024

285

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Loss of Glucocorticoid Fast Feedback in Depression

3 December 2024

286

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory

3 December 2024

287

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

On the nature and pattern of neurocognitive function in major depressive disorder

3 December 2024

288

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

3 December 2024

289

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat

3 December 2024

290

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

3 December 2024

291

1 reference

https://api.crossref.org/works/10.1016/J.PHARMTHERA.2011.05.007

3 December 2024

Identifiers

1 reference

24 August 2017

1 reference